Ligand profile
SL7
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_04637 — L-lactate dehydrogenase cytochrome
Identifiers
Database identifiers and provenance.
- Ligand ID
SL7- PDB
6w4c- UniProt (similar protein)
Q9UJM8- Target protein
- KP13_04637
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 140.4
- −1 ≤ LogP ≤ 5 2.69
- MW ≤ 500 Da 394.4
- LogP ≤ 5 2.69
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 140.4
Matches PAINS filter: mannich_A(296). May be a frequent false positive in HTS — review carefully.
Chemical representations
Canonical representations for cheminformatics workflows.
CN(C)c1nc(on1)c2cccc(c2O)CNc3ccc4c(c3)c([nH]n4)C(=O)OCN(C)c1nc(on1)c2cccc(c2O)CNc3ccc4c(c3)c([nH]n4)C(=O)O
InChI=1S/C19H18N6O4/c1-25(2)19-21-17(29-24-19)12-5-3-4-10(16(12)26)9-20-11-6-7-14-13(8-11)15(18(27)28)23-22-14/h3-8,20,26H,9H2,1-2H3,(H,22,23)(H,27,28)InChI=1S/C19H18N6O4/c1-25(2)19-21-17(29-24-19)12-5-3-4-10(16(12)26)9-20-11-6-7-14-13(8-11)15(18(27)28)23-22-14/h3-8,20,26H,9H2,1-2H3,(H,22,23)(H,27,28)
QZFNTDYKERMDQJ-UHFFFAOYSA-NQZFNTDYKERMDQJ-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF01070
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand SL7 →
- PDB RCSB structure 6w4c →
- UniProt UniProt Q9UJM8 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “SL7”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_04637.
PDB 40
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).